[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946
Sort by:

Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 59 pages

Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hematopoietic Stem Cell Transplantation Drugs in Development by Stages,...

May 2022 46 pages

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hemoglobin Subunit...

May 2022 47 pages

Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 36 pages

Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, Mo...

May 2022 43 pages

Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Targ...

May 2022 120 pages

Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 167 pages

Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 44 pages

Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 36 pages

Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 46 pages

Hepacivirin (NS3-4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hepacivirin (NS3-4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepacivirin (NS3/4...

May 2022 45 pages

Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 46 pages

Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 38 pages

Hepatitis B Virus Surface Antigen (HBsAg) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hepatitis B Virus Surface Antigen (HBsAg) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis B Virus Surface Antigen (HBsAg) Drugs...

May 2022 72 pages

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis C Virus Envelope Protein E1 Drugs in Deve...

May 2022 36 pages

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 38 pages

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and In...

May 2022 104 pages

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 328 pages

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 39 pages

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 117 pages

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H1 Receptor (HRH1) Drugs in Development by Therapy...

May 2022 69 pages

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H3 Rece...

May 2022 41 pages

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hist...

May 2022 47 pages

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs...

May 2022 202 pages

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 36 pages

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy A...

May 2022 47 pages

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 47 pages

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Develop...

May 2022 51 pages

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA...

May 2022 38 pages

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA,...

May 2022 59 pages

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 42 pages

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Cytomegalovirus Glycoprotein H (gH) Drugs...

May 2022 35 pages

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 46 pages

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 131 pages

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E6 (E6) Drugs in Develo...

May 2022 65 pages

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E7 (E7) Drugs in Develo...

May 2022 77 pages

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Ta...

May 2022 35 pages

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS Co...

May 2022 38 pages

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS corona...

May 2022 40 pages

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 35 pages

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages...

May 2022 36 pages

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 146 pages

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 42 pages

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 64 pages

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 41 pages

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 41 pages

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA...

May 2022 42 pages

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target,...

May 2022 63 pages

Filters

Clear all

Search

Categories

209
1,199
32
238
214
187
155
140
64,297
1,312
1,311
2,468
184

Publishers

179
1
1,431
239
366
389
103
148
348
3
202
3
6
1,620
487
80
123
208
112
25
1,049
378
23
40
68
510
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,709
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
384
8
3
18
58
907
6
89
12
24
15
1,285
227
128
386
3
74
10
119
227
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
797
497
2
2
2
118
197
102
54
23
708
26
135
530
177
646
66,872

Price

—

Date

—

Pages

—

Offers

1
280
1
1